+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

Urinary Tract Cancer Market - By Type, By Treatment - Global Industry Perspective Comprehensive Analysis and Forecast 2020 - 2026

  • ID: 5144175
  • Report
  • August 2020
  • Region: Global
  • 110 pages
  • Zion Market Research
According to the report, global demand for Urinary Tract Cancer market was valued at approximately USD 2.4 billion in 2019, and is expected to generate revenue of around USD 9.3 billion by end of 2026, growing at a CAGR of around 21.1% between 2020 and 2026.

Cancer is the adverse disease caused due to abnormal cell growth with potential to spread or invade to all over the body. Urinary tract cancer is generally known as bladder cancer. Uncontrolled growth of cells in the urinary tract is said as bladder cancer. The bladder cancer is recognized from the most common symptoms that is presence of blood in urine. The urine tract cancer is mainly observed among smokers, generic population, workers in chemical industries and people with prolonged urine infections. Patient can be survived in the bladder cancer if identified at early stages.

The report provides a comprehensive view on the urinary tract cancer market we have included a detailed value chain analysis. To understand the competitive landscape in the market, an analysis of Porter’s Five Forces model for the urinary tract cancer market has also been included. The study encompasses a market attractiveness analysis, wherein product segments are benchmarked based on their market size, growth rate and general attractiveness. The report also analyzes several driving and restraining factors and their impact on the market during the forecast period.

Increasing consumption of cigarettes globally coupled with increasing sedentary lifestyle had increased the incidence of urinary tract cancer. Accomplishment from the government to generate awareness regarding the urinary tract cancer and advance modern medications drives the urinary tract cancer market. Lack of awareness in the developing countries may suppress the growth of urinary tract cancer market. Nevertheless, untapped techniques for treatment of urinary tract cancer are likely to open new opportunities for the urinary tract cancer market in the coming years.

Based on type the urinary tract cancer market can be segmented as squamous cell carcinoma, adenocarcinoma and urothelial carcinoma among others. Urothelial carcinoma is leading segment with 95% of incidence rate, globally. On basis of diagnostic techniques, the urinary tract cancer market is segmented into, cystoscopy, transurethral resection of tumor, imaging tests and urine analyses among others. Different treatments for the urinary tract cancer include chemotherapy, intravesical therapy, radiation therapy, and surgery.

North America and Europe dominated the urinary tract cancer market owing to high prevalence rate of urinary tract cancer, increasing healthcare expenditure and sophisticated healthcare sector. Asia Pacific is expected to experience fastest growth in the forecast period. Factors such as increasing awareness, growing healthcare sector and rising government support for research and development are the driving factors for the urinary tract cancer market in these region.

Shionogi & Co., Ltd., Medical Enzymes AG, Amgen Inc, Spectrum pharmaceuticals, Bristol-Myers Squibb Company, F. Hoffmann-La Roche Ltd, Boehringer Ingelheim GmbH, IkerChem S.L., Kyowa Hakko Kirin Co., Ltd and Genzyme Corporation among others are some of the leading players for the urinary tract cancer market.

The report segments of the urinary tract cancer market into:

Urinary Tract Cancer Market: Type Segment Analysis
  • Squamous cell carcinoma
  • Adenocarcinoma
  • Urothelial carcinoma a
  • Other
Urinary Tract Cancer Market: Diagnostic Techniques Segment Analysis
  • Cystoscopy
  • Transurethral resection of tumor
  • Imaging tests
  • Urine analyses
  • Others
Urinary Tract Cancer Market: Treatment Segment Analysis
  • Chemotherapy
  • Intravesical therapy
  • Radiation therapy
  • Surgery
Urinary Tract Cancer Market: Regional Segment Analysis
  • North America
  • U.S.
  • Europe
  • UK
  • France
  • Germany
  • Asia Pacific
  • China
  • Japan
  • India
  • Latin America
  • Brazil
  • Middle East & Africa
Note: Product cover images may vary from those shown
  • Chapter 1. Preface
    • 1.1. Report Description and Scope
    • 1.2. Research Scope
    • 1.3. Research Methodology
      • 1.3.1. Market Research Process
      • 1.3.2. Market Research Methodology
  • Chapter 2. Executive Summary
    • 2.1. Urinary Tract Cancer Market, 2016 - 2026, (USD Million)
    • 2.2. Urinary Tract Cancer Market: Snapshot
  • Chapter 3. Global Urinary Tract Cancer Market – Industry Analysis
    • 3.1. Urinary Tract Cancer Market: Market Dynamics
    • 3.2. Market Drivers
      • 3.2.1. Increasing consumption of cigarettes
      • 3.2.2. Increasing sedentary lifestyle
    • 3.3. Restraints
      • 3.3.1. Lack of awareness in the developing countries
    • 3.4. Opportunity
      • 3.4.1. Untapped techniques for treatment of urinary tract cancer
    • 3.5. Porter’s Five Forces Analysis
    • 3.6. Market Attractiveness Analysis
      • 3.6.1. Market attractiveness analysis by Type segment
      • 3.6.2. Market attractiveness analysis by Diagnostic Techniques segment
      • 3.6.3. Market attractiveness analysis by Treatment segment
      • 3.6.4. Market attractiveness analysis by regional segment
  • Chapter 4. Global Urinary Tract Cancer Market - Competitive Landscape
    • 4.1. Company market share analysis
      • 4.1.1. Global Urinary Tract Cancer market: company market share analysis, 2019
    • 4.2. Strategic development
      • 4.2.1. Acquisitions & mergers
      • 4.2.2. New Diagnostic Techniques launches
      • 4.2.3. Agreements, partnerships, collaborations and joint ventures
      • 4.2.4. Research and development and regional expansion
  • Chapter 5. Global Urinary Tract Cancer Market – Type Segment Analysis
    • 5.1. Global Urinary Tract Cancer market overview: by Type
      • 5.1.1. Global Urinary Tract Cancer market revenue share, by Type, 2019 and 2026
    • 5.2. Squamous cell carcinoma
      • 5.2.1. Global Urinary Tract Cancer market by Squamous cell carcinoma, 2016-2026 (USD Million)
    • 5.3. Adenocarcinoma
      • 5.3.1. Global Urinary Tract Cancer market by Adenocarcinoma, 2016-2026 (USD Million)
    • 5.4. Urothelial carcinoma
      • 5.4.1. Global Urinary Tract Cancer market by Urothelial carcinoma, 2016-2026 (USD Million)
    • 5.5. Others
      • 5.5.1. Global Urinary Tract Cancer market by Others, 2016-2026 (USD Million)
  • Chapter 6. Global Urinary Tract Cancer Market – Diagnostic Techniques Segment Analysis
    • 6.1. Global Urinary Tract Cancer market overview: by Diagnostic Techniques
      • 6.1.1. Global Urinary Tract Cancer market revenue share, by Diagnostic Techniques, 2019 and 2026
    • 6.2. Cystoscopy
      • 6.2.1. Global Urinary Tract Cancer market by Cystoscopy, 2016-2026 (USD Million)
    • 6.3. Transurethral resection of tumor
      • 6.3.1. Global Urinary Tract Cancer market by Transurethral resection of tumor, 2016-2026 (USD Million)
    • 6.4. Imaging tests
      • 6.4.1. Global Urinary Tract Cancer market by Imaging tests, 2016-2026 (USD Million)
    • 6.5. Urine analyses
      • 6.5.1. Global Urinary Tract Cancer market by Urine analyses, 2016-2026 (USD Million)
    • 6.6. Others
      • 6.6.1. Global Urinary Tract Cancer market by Others, 2016-2026 (USD Million)
  • Chapter 7. Global Urinary Tract Cancer Market – Treatment Segment Analysis
    • 7.1. Global Urinary Tract Cancer market overview: by Treatment
      • 7.1.1. Global Urinary Tract Cancer market revenue share, by Treatment, 2019 and 2026
    • 7.2. Chemotherapy
      • 7.2.1. Global Urinary Tract Cancer market by Chemotherapy, 2016-2026 (USD Million)
    • 7.3. Intravesical therapy
      • 7.3.1. Global Urinary Tract Cancer market by Intravesical therapy, 2016-2026 (USD Million)
    • 7.4. Radiation therapy
      • 7.4.1. Global Urinary Tract Cancer market by Radiation therapy, 2016-2026 (USD Million)
    • 7.5. Surgery
      • 7.5.1. Global Urinary Tract Cancer market by Surgery, 2016-2026 (USD Million)
  • Chapter 8. Global Urinary Tract Cancer Market - Regional Analysis
    • 8.1. Global Urinary Tract Cancer market overview: by region
      • 8.1.1. Global Urinary Tract Cancer market revenue share, by region, 2019 and 2026
    • 8.2. North America
      • 8.2.1. North America Urinary Tract Cancer market, by country, 2016-2026 (USD Million)
      • 8.2.2. North America Urinary Tract Cancer market revenue, by Type, 2016-2026 (USD Million)
      • 8.2.3. North America Urinary Tract Cancer market revenue, by Diagnostic Techniques, 2016-2026 (USD Million)
      • 8.2.4. North America Urinary Tract Cancer market revenue, by Treatment, 2016-2026 (USD Million)
      • 8.2.5. The U.S.
        • 8.2.5.1. The U.S. Urinary Tract Cancer market revenue, by Type, 2016-2026 (USD Million)
        • 8.2.5.2. The U.S. Urinary Tract Cancer market revenue, by Diagnostic Techniques, 2016-2026 (USD Million)
        • 8.2.5.3. The U.S. Urinary Tract Cancer market revenue, by Treatment, 2016-2026 (USD Million)
      • 8.2.6. Rest of North America
        • 8.2.6.1. Rest of North America Urinary Tract Cancer market revenue, by Type, 2016-2026 (USD Million)
        • 8.2.6.2. Rest of North America Urinary Tract Cancer market revenue, by Diagnostic Techniques, 2016-2026 (USD Million)
        • 8.2.6.3. Rest of North America Urinary Tract Cancer market revenue, by Treatment, 2016-2026 (USD Million)
    • 8.3. Europe
      • 8.3.1. Europe Urinary Tract Cancer market, by country, 2016-2026 (USD Million)
      • 8.3.2. Europe Urinary Tract Cancer market revenue, by Type, 2016-2026 (USD Million)
      • 8.3.3. Europe Urinary Tract Cancer market revenue, by Diagnostic Techniques, 2016-2026 (USD Million)
      • 8.3.4. Europe Urinary Tract Cancer market revenue, by Treatment, 2016-2026 (USD Million)
      • 8.3.5. U.K.
        • 8.3.5.1. U.K. Urinary Tract Cancer market revenue, by Type, 2016-2026 (USD Million)
        • 8.3.5.2. U.K. Urinary Tract Cancer market revenue, by Diagnostic Techniques, 2016-2026 (USD Million)
        • 8.3.5.3. U.K. Urinary Tract Cancer market revenue, by Treatment, 2016-2026 (USD Million)
      • 8.3.6. France
        • 8.3.6.1. France Urinary Tract Cancer market revenue, by Type, 2016-2026 (USD Million)
        • 8.3.6.2. France Urinary Tract Cancer market revenue, by Diagnostic Techniques, 2016-2026 (USD Million)
        • 8.3.6.3. France Urinary Tract Cancer market revenue, by Treatment, 2016-2026 (USD Million)
      • 8.3.7. Germany
        • 8.3.7.1. Germany Urinary Tract Cancer market revenue, by Type, 2016-2026 (USD Million)
        • 8.3.7.2. Germany Urinary Tract Cancer market revenue, by Diagnostic Techniques, 2016-2026 (USD Million)
        • 8.3.7.3. Germany Urinary Tract Cancer market revenue, by Treatment, 2016-2026 (USD Million)
      • 8.3.8. Rest of Europe
        • 8.3.8.1. Rest of Europe Urinary Tract Cancer market revenue, by Type, 2016-2026 (USD Million)
        • 8.3.8.2. Rest of Europe Urinary Tract Cancer market revenue, by Diagnostic Techniques, 2016-2026 (USD Million)
        • 8.3.8.3. Rest of Europe Urinary Tract Cancer market revenue, by Treatment, 2016-2026 (USD Million)
    • 8.4. Asia Pacific
      • 8.4.1. Asia Pacific Urinary Tract Cancer market, by country, 2016-2026 (USD Million)
      • 8.4.2. Asia Pacific Urinary Tract Cancer market revenue, by Type, 2016-2026 (USD Million)
      • 8.4.3. Asia Pacific Urinary Tract Cancer market revenue, by Diagnostic Techniques, 2016-2026 (USD Million)
      • 8.4.4. Asia Pacific Urinary Tract Cancer market revenue, by Treatment, 2016-2026 (USD Million)
      • 8.4.5. China
        • 8.4.5.1. China Urinary Tract Cancer market revenue, by Type, 2016-2026 (USD Million)
        • 8.4.5.2. China Urinary Tract Cancer market revenue, by Diagnostic Techniques, 2016-2026 (USD Million)
        • 8.4.5.3. China Urinary Tract Cancer market revenue, by Treatment, 2016-2026 (USD Million)
      • 8.4.6. Japan
        • 8.4.6.1. Japan Urinary Tract Cancer market revenue, by Type, 2016-2026 (USD Million)
        • 8.4.6.2. Japan Urinary Tract Cancer market revenue, by Diagnostic Techniques, 2016-2026 (USD Million)
        • 8.4.6.3. Japan Urinary Tract Cancer market revenue, by Treatment, 2016-2026 (USD Million)
      • 8.4.7. India
        • 8.4.7.1. India Urinary Tract Cancer market revenue, by Type, 2016-2026 (USD Million)
        • 8.4.7.2. India Urinary Tract Cancer market revenue, by Diagnostic Techniques, 2016-2026 (USD Million)
        • 8.4.7.3. India Urinary Tract Cancer market revenue, by Treatment, 2016-2026 (USD Million)
      • 8.4.8. Rest of Asia Pacific
        • 8.4.8.1. Rest of Asia Pacific Urinary Tract Cancer market revenue, by Type, 2016-2026 (USD Million)
        • 8.4.8.2. Rest of Asia Pacific Urinary Tract Cancer market revenue, by Diagnostic Techniques, 2016-2026 (USD Million)
        • 8.4.8.3. Rest of Asia Pacific Urinary Tract Cancer market revenue, by Treatment, 2016-2026 (USD Million)
    • 8.5. Latin America
      • 8.5.1. Latin America Urinary Tract Cancer market, by country, 2016-2026 (USD Million)
      • 8.5.2. Latin America Urinary Tract Cancer market revenue, by Type, 2016-2026 (USD Million)
      • 8.5.3. Latin America Urinary Tract Cancer market revenue, by Diagnostic Techniques, 2016-2026 (USD Million)
      • 8.5.4. Latin America Urinary Tract Cancer market revenue, by Treatment, 2016-2026 (USD Million)
      • 8.5.5. Brazil
        • 8.5.5.1. Brazil Urinary Tract Cancer market revenue, by Type, 2016-2026 (USD Million)
        • 8.5.5.2. Brazil Urinary Tract Cancer market revenue, by Diagnostic Techniques, 2016-2026 (USD Million)
        • 8.5.5.3. Brazil Urinary Tract Cancer market revenue, by Treatment, 2016-2026 (USD Million)
      • 8.5.6. Rest of Latin America
        • 8.5.6.1. Rest of Latin America Urinary Tract Cancer market revenue, by Type, 2016-2026 (USD Million)
        • 8.5.6.2. Rest of Latin America Urinary Tract Cancer market revenue, by Diagnostic Techniques, 2016-2026 (USD Million)
        • 8.5.6.3. Rest of Latin America Urinary Tract Cancer market revenue, by Treatment, 2016-2026 (USD Million)
    • 8.6. Middle East & Africa
      • 8.6.1. Middle East & Africa Urinary Tract Cancer market, 2016-2026 (USD Million)
      • 8.6.2. Middle East & Africa Urinary Tract Cancer market revenue, by Type, 2016-2026 (USD Million)
      • 8.6.3. Middle East & Africa Urinary Tract Cancer market revenue, by Diagnostic Techniques, 2016-2026 (USD Million)
      • 8.6.4. Middle East & Africa Urinary Tract Cancer market revenue, by Treatment, 2016-2026 (USD Million)
  • Chapter 9. Company Profiles
    • 9.1. Shionogi & Co., Ltd.
      • 9.1.1. Overview
      • 9.1.2. Financials
      • 9.1.3. Product portfolio
      • 9.1.4. Business Strategy
      • 9.1.5. Recent Developments
    • 9.2. Medical Enzymes AG
      • 9.2.1. Overview
      • 9.2.2. Financials
      • 9.2.3. Product portfolio
      • 9.2.4. Business Strategy
      • 9.2.5. Recent Developments
    • 9.3. Amgen Inc
      • 9.3.1. Overview
      • 9.3.2. Financials
      • 9.3.3. Product portfolio
      • 9.3.4. Business Strategy
      • 9.3.5. Recent Developments
    • 9.4. Spectrum pharmaceuticals.
      • 9.4.1. Overview
      • 9.4.2. Financials
      • 9.4.3. Product portfolio
      • 9.4.4. Business Strategy
      • 9.4.5. Recent Developments
    • 9.5. Bristul-Myers Squibb Company
      • 9.5.1. Overview
      • 9.5.2. Financials
      • 9.5.3. Product portfolio
      • 9.5.4. Business Strategy
      • 9.5.5. Recent Developments
    • 9.6. F. Hoffmann-La Roche Ltd
      • 9.6.1. Overview
      • 9.6.2. Financials
      • 9.6.3. Product portfolio
      • 9.6.4. Business Strategy
      • 9.6.5. Recent Developments
    • 9.7. Boehringer Ingelheim GmbH
      • 9.7.1. Overview
      • 9.7.2. Financials
      • 9.7.3. Product portfolio
      • 9.7.4. Business Strategy
      • 9.7.5. Recent Developments
    • 9.8. IkerChem S.L
      • 9.8.1. Overview
      • 9.8.2. Financials
      • 9.8.3. Product portfolio
      • 9.8.4. Business Strategy
      • 9.8.5. Recent Developments
    • 9.9. Kyowa Hakko Kirin Co., Ltd.
      • 9.9.1. Overview
      • 9.9.2. Financials
      • 9.9.3. Product portfolio
      • 9.9.4. Business Strategy
      • 9.9.5. Recent Developments
    • 9.10. Genzyme Corporation
      • 9.10.1. Overview
      • 9.10.2. Financials
      • 9.10.3. Product portfolio
      • 9.10.4. Business Strategy
      • 9.10.5. Recent Developments
Note: Product cover images may vary from those shown
Adroll
adroll